RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding RenovoRx, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 8 | 1 | 9 | +2 |
| Shares | 169.1K | 11.1K | 104.4K | −53.7K (−34.0%) |
| Value | $1.02M | $67.0K | $506.0K | −$451.0K (−47.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held RenovoRx, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 13,208 | $64.0K | 0.01% |
| Verition Fund Management LLC | 10,283 | $50.0K | 0.00% |
| UBS Group AG | 4,512 | $22.0K | 0.00% |
| Carmichael Hill & Associates, Inc. | 200 | $1.00K | 0.00% |
| Wells Fargo & Company | 11 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 16 | $0 | 0.00% |
Sold out (4)
Institutions that held RenovoRx, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 20,569 | $125.0K |
| Two Sigma Securities, LLC | 17,944 | $108.0K |
| Citadel Advisors LLC | 12,010 | $73.0K |
| Bank of America Corp | 100 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held RenovoRx, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Harbor Financial Services, LLC | 11,100 | $67.0K |